Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients.

Ilaria MassaOriana NanniFlavia FocaMarco MaltoniStefania DerniNicola GentiliGiovanni Luca FrassinetiAndrea Casadei GardiniMartina ValgiustiDino AmadoriElena PratiMattia AltiniDavide GallegatiElisabetta Sansoni

Published in: BMC palliative care (2018)

According to the criteria used, our Institute provides a good quality of cancer care for dying colorectal cancer patients, measured by the use of chemotherapy and referral to hospice in their last days of life.

Keyphrases

palliative care
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
squamous cell carcinoma
advanced cancer
patient reported outcomes
papillary thyroid
rectal cancer